Abstract Background and Purpose Drug hypersensitivity reactions (DHRs) associated with a specific human leukocyte antigen (HLA) allotype do not manifest uniformly in all individuals within an HLA model population. This scenario highlights the complexity of predicting drug hypersensitivity reaction risk without considering additional factors ...
Takeshi Susukida +7 more
wiley +1 more source
Creating unimolecular multivalent diversity in protein conjugates via the Passerini multicomponent bioconjugation with isocyanoproteins. [PDF]
Humpierre AR +11 more
europepmc +1 more source
Optimizing Clinical Practice and Efficacy Evaluation of Radiotherapy Combined with Immunotherapy in Recurrent Esophageal Cancer: A Retrospective Cohort Study Focusing on Patient-Reported Pain Relief and Tumor Proliferation Inhibition. [PDF]
Ji J, Dong L, Huang B, Luo S.
europepmc +1 more source
Integrative Approach to Develop and Characterize Antibodies against the Cancer-Associated Antigen Sialyl Lewis A (CA 19-9). [PDF]
Freitag A +14 more
europepmc +1 more source
Glycosyl Coumarins as Selective Inhibitors of Tumor-Associated Carbonic Anhydrase IX and XII: Synthesis, Structure-Activity Relationships, and Molecular Modeling. [PDF]
Le Pors MS +5 more
europepmc +1 more source
Prognostic Value of Combined Carbohydrate Antigen 19-9 and Duke Pancreatic Monoclonal Antigen Type 2 Assessment in Biliary Tract Cancer. [PDF]
Shintakuya R +9 more
europepmc +1 more source
Xenotransplantation: lessons from history, genetic engineering, and early clinical experience-an interview with Dr. David K. C. Cooper. [PDF]
Abdi R.
europepmc +1 more source
Glycan-encoded immune checkpoints and allorecognition: a mechanistic framework for transplantation and organ engineering. [PDF]
Rana MM +3 more
europepmc +1 more source
Current and evolving practices of carbohydrate antigens in gastric cancer: a narrative review. [PDF]
Zhao S, Li K, Wang H, Ding Y, Li D.
europepmc +1 more source
GALNT7 promotes the malignant progression of gastrointestinal stromal tumors by regulating KIT O-GalNAc glycosylation. [PDF]
Liu J +9 more
europepmc +1 more source

